1069 — China Health Technology Holding Income Statement
0.000.00%
Last trade - 00:00- HK$46.32m
- HK$169.40m
- CNY90.22m
- 32
- 92
- 22
- 46
Annual income statement for China Health Technology Holding, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.
R2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 18 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 6.76 | 58.7 | 47.6 | 90.2 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0 | 11.5 | 1.9 | 8.21 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 513 | 5.92 | 56.4 | -156 | 63.7 |
| Operating Profit | -513 | 0.836 | 2.31 | 203 | 26.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -547 | -20.4 | -9.37 | 200 | 23 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -547 | -20.4 | -10.8 | 200 | 22.7 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -554 | -18.9 | -10.8 | 200 | 22.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -554 | -18.9 | -10.8 | 200 | 22.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -5.64 | -2.97 | -3.22 | 0.805 | -0.001 |
| Dividends per Share |